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Synthesis and evaluation of some new 1,3,4-oxadiazoles 
bearing thiophene, thiazole, coumarin, pyridine and pyridazine 
derivatives as antiviral agents
In an attempt to produce heterocyclic compounds based on 
1,3,4-oxadiazole derivatives with potential antiviral activity, syn-
thesis of compound 1 [2-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-
2-yl)acetonitrile] was performed through the reaction of cyano-
acetic acid hydrazide with carbon disulfide in alcoholic potassium 
hydroxide. Compound 1 has an activating methylene group, so it 
was directed toward some specific reactions. Thus, aryldiazonium 
chlorides reacted with compound 1 affording hydrazono deriva-
tives 2a-c. Also, aromatic aldehydes reacted with compound 1 
to produce compounds 3a,b. Furthermore, cyclic ketones were 
 subjected to the synthesis of fused thiophene derivatives 4a,b via 
reaction with compound 1 in the presence of elemental sulfur. In 
addition, 1,3,4-oxadiazole derivative 1, when reacted with iso-
thiocyanates, salicylaldehyde or 1,3-dicarbonyl compounds, 
formed thiazole derivatives 5a,b, coumarin derivative 6 and alke-
nyl derivatives 7a,b resp. Compound 7b underwent cyclization to 
afford pyridine derivative 8. Arylhydrazono derivatives 9a,b 
were produced through the reaction of compound 7a with aryl-
diazonium chlorides. Products 9a,b underwent cyclization to 
produce pyridazine derivatives 10a,b. Finally, 1,3,4-oxadiazole 
derivative 1 was directed toward reaction with hydrazine deriva-
tives, bromoacetophenone and ethylchloroacetate affording com-
pounds 11a,b, 12 and 13, resp. Fused thiophene derivatives 14a,b 
were produced via reaction of compounds 4a,b with a mixture of 
malononitrile and ethylorthoformate. Antiviral activity of the 
synthesized products showed that 5-(4-amino-3-ethyl-
2-thioxo-2,3-dihydrothiazol-5-yl)-1,3,4-oxadiazole-2(3H)-thione 
(5a) and 5-(4-amino-3-phenyl-2-thioxo-2,3-dihydrothiazol-5-yl)-
1,3,4-oxadiazole-2(3H)-thione (5b) acted as the most active agents 
against Feline herpes virus, Feline corona virus, Herpes simplex virus-1 
and Herpes simplex virus-2, whereas compound 2-(5-(2-phenyl- 
hydrazono)-4,5-dihydro-1,3,4-oxadiazol-2-yl)acetonitrile (11b) 
was the most effective against Vaccinia virus, Herpes simplex virus 
(TK-KOS-ACVr), Coxsackie virus B4 and Vesicular stomatitis virus.
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1,3,4-Oxadiazole heterocyclic ring is one of the most important heterocyclic moieties 
because of its versatile biological actions. In particular, heterocyclic compounds bearing 
such a ring are known to exert potential antitubercular activity (1), antiinflammatory and 
analgesic activities (2), antiviral activity (3), anticancer activity and antimicrobial activity 
(4, 5). Also, 1,3,4-oxadiazole bearing fused thiophene derivatives have antioxidant activity 
(6). In addition, 1,3,4-oxadiazole containing thiazole moiety shows antimicrobial and cy-
totoxic activities (7). It was found that oxadiazole bearing chromene derivatives have po-
tential antibacterial and antifungal properties (8). Furthermore, pyridazine derivatives 
show interesting antifungal activity (9). Also, phenyl-bearing oxadiazole exerts versatile 
biological properties, such as antimicrobial and cytotoxic activity (10, 11) and anti-inflam-
matory activity (12). On the other hand, 5-substituted-2-mercapto-1,3,4-oxadiazoles show 
analgesic, antitubercular and anticonvulsant properties (13).  
EXPERIMENTAL
Melting points of all the synthesized compounds were determined in open capillaries 
and were uncorrected. Elemental analyses were performed on a Yanaco CHNS Corder 
elemental analyzer (Japan). Structures of the synthesized compounds were established 
using IR, 1H NMR, 13C NMR and mass spectrometry techniques (Tables I and II). IR spec-
tra were measured using KBr discs on a Pye Unicam SP-1000 spectrophotometer (Pye Uni-
cam, UK). 1H NMR and 13C NMR spectral analyses were performed on a Varian EM 390-
200 MHz instrument (Varian, Germany) in CD3SOCD3 as solvent and TMS as internal 
standard. Chemical shifts were expressed as δ ppm. Mass spectra were recorded on Kratos 
(75 eV) MS equipment (Germany).
Syntheses
2-(5-Thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)acetonitrile (1). – A mixture of potassium 
hydroxide aqueous solution in ethanol (2.5 g in 50 mL) and carbon disulfide (9.0 mL, 0.15 
mol) was added to cyanoacetic acid hydrazide (4.95 g, 0.05 mol). The reaction mixture was 
heated under reflux until the hydrogen sulfide odor disappeared (within 10 h). The mix-
ture was then poured onto ice-water containing a few drops of 2 mol L–1 HCl. The formed 
solid product was filtered out, washed with water, dried and recrystallized from ethanol 
to afford the desired product.
N’-phenyl-5-thioxo-4,5-dihydro-1,3,4-oxadiazole-2-carbohydrazonoyl cyanide (2a), N’-(4-
chlorophenyl)-5-thioxo-4,5-dihydro-1,3,4-oxadiazole-2-carbohydrazonoyl cyanide (2b) and N’-(4-
methoxyphenyl)-5-thioxo-4,5-dihydro1,3,4-oxadiazole-2-carbohydrazonoyl cyanide (2c). – Either 
benzenediazonium chloride, 4-chlorobenzenediazonium chloride or 4-methoxybenzene-
diazonium chloride (0.003 mol) [prepared by adding an aqueous sodium nitrite solution 
(0.207 g, 0.003 mol) to a cold solution of either aniline, 4-chloroaniline or 4-methoxyaniline 
(0.003 mol) in the appropriate amount of glacial acetic acid at 0–5 °C, under continuous 
stirring] was added to a cold solution (0–5 °C) of 1,3,4-oxadiazole derivative 1 (0.423 g, 
0.003 mol) in ethanol (50 mL) containing sodium acetate (0.246 g, 0.003 mol), under con-
tinuous stirring. The reaction mixture was stirred at room temperature for additional 3 h 
and the solid product so formed, in each case, was collected by filtration and recrystallized 
from ethanol.
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3-Phenyl-2-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)acrylonitrile (3a) and 
3-(4-chlorophenyl)-2-(5-thioxo-4,5-dihydro1,3,4-oxadiazol-2-yl)acrylonitrile (3b). – Either benz-
aldehyde (0.318 g, 0.003 mol) or 4-chlorobenzaldehyde (0.421 g, 0.003 mol) was added to a 
solution of compound 1 (0.423 g, 0.003 mol) in ethanol (50 mL) containing piperidine (0.5 
mL). The reaction mixture was heated under reflux for 4 h and then poured onto ice/water 
containing a few drops of HCl. Suction filtration was used to collect the precipitate.
5-(3-Amino-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)-1,3,4-oxadiazole-2(3H)-thione (4a) 
and 5-(3-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-1,3,4-oxadiazole-2(3H)-thione (4b). – 
Either cyclopentanone (0.252 g, 0.003 mol) or cyclohexanone (0.294 g, 0.003 mol) together 
with elemental sulfur (0.096 g, 0.003 mol) were added to a solution of 1,3,4-oxadiazole de-
rivative 1 (0.423 g, 0.003 mol) in ethanol (40 mL) containing triethylamine (0.5 mL). The 
reaction mixture was heated under reflux for 3 h, cooled and poured onto an ice/water 
mixture containing a few drops of HCl. The solid product that formed in each case was 
collected by filtration and recrystallized from 1,4-dioxane.
5-(4-Amino-3-ethyl-2-thioxo-2,3-dihydrothiazol-5-yl)-1,3,4-oxadiazole-2(3H)-thione (5a) 
and 5-(4-amino-3-phenyl-2-thioxo-2,3-dihydrothiazol-5-yl)-1,3,4-oxadiazole-2(3H)-thione (5b). – 
Either ethylisothiocyanate (0.261 g, 0.003 mol) or phenylisothiocyanate (0.406 g, 0.003 mol) 
was added to a solution of 1,3,4-oxadiazole derivative 1 (0.423 g, 0.003 mol) in ethanol (50 mL) 
containing 0.5 mL of triethylamine. The reaction mixture was refluxed for 3 h, cooled and 
poured onto an ice/water mixture containing a few drops of HCl. The formed precipitate 
in each case was filtered off and recrystallized from 1,4-dioxane.
3-(5-Thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-2H-chromen-2-one (6). – Salicylaldehyde 
(0.366 g, 0.003 mol) was added to a solution of 1,3,4-oxadiazole derivative 1 (0.423 g, 0.003 
mol) in 1,4-dioxane (40 mL) containing piperidine (0.5 mL). The reaction mixture was heat-
ed under reflux for 4 h and then evaporated under vacuum. The solid product was tritu-
rated with ethanol and the formed solid product was collected by filtration and recrystal-
lized from 1,4-dioxane.
3-Methyl-5-oxo-2-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)hex-2-enenitrile (7a) and 4-cy-
ano-3-methyl-N-phenyl-4-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)but-3-enamid (7b). – A 
mixture of 1,3,4-oxadiazole derivative 1 (0.423 g, 0.003 mol) and either acetyl acetone (0.3 
g, 0.003 mol) or acetoacetanilide (0.531 g, 0.003 mol) containing a catalytic amount of pi-
peridine (0.5 mL) was fused at 140 °C for 30 min. It was then left to cool and the formed 
solid product in each case was collected by filtration and dried. It was then recrystallized 
from ethanol.
6-Amino-4-methyl-1-phenyl-5-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)pyridin-2(1H)-
one (8). – Compound (7b, 0.3 g, 0.001 mol.) was dissolved in 50 mL of ethanol and 0.5 mL of 
triethylamine was added. The solution was then subjected to heating under reflux for 3 h 
aiming at formation of a cyclized product. The solution was cooled, poured onto ice water, 
a few drops of HCl were added to enhance precipitate formation and the latter product was 
then collected by filtration and recrystallized from ethanol.
3-Methyl-5-oxo-4-(2-phenylhydrazono)-2-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)hex-
2-enenitrile (9a) and 4-(2-(4-chlorophenyl)hydrazono)-3-methyl-5-oxo-2-(5-thioxo-4,5-dihydro 
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-1,3,4-oxadiazol-2-yl)hex-2-enenitrile (9b). – Either benzenediazonium chloride or 4-chloro-
benzenediazonium chloride (0.002 mol) [prepared by adding an aqueous sodium nitrite 
solution (0.138 g, 0.002 mol) to a cold solution of either aniline or 4-chloroaniline (0.002 mol) 
in an appropriate amount of conc. HCl at 0–5 °C, under continuous stirring] was added to 
a cold solution (0–5 °C) of compound 7a (0.446 g, 0.002 mol) in ethanol (50 mL), containing 
sodium hydroxide (0.08 g, 0.002 mol), under continuous stirring. The reaction mixture was 
stirred at room temperature for additional 4 h and the formed solid product in each case 
was collected and recrystallized from 1,4-dioxane.
1-(6-Imino-4-methyl-1-phenyl-5-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-1,6-dihydro-
pyridazin-3-yl) ethanone (10a) and 1-(1-(4-chlorophenyl)-6-imino-4-methyl-5-(5-thioxo-4,5-di-
hydro-1,3,4-oxadiazol-2-yl)-1,6-dihydropyridazin-3-yl)ethanone (10b). – A solution of each com-
pound 9a (0.654 g, 0.002 mol) or 9b (0.724 g, 0.002 mol) in 50 mL ethanol (containing 
catalytic amount of trimethylamine, 0.5 mL) was heated under reflux for 4 h and poured 
onto an ice/water mixture containing a few drops of hydrochloric acid. The solid product 
so formed was collected by filtration and recrystallized from ethanol.
2-(5-Hydrazono-4,5-dihydro-1,3,4-oxadiazol-2-yl)acetonitrile (11a) and 2-(5-(2-phenyl- 
hydrazono)-4,5-dihydro-1,3,4-oxadiazol-2-yl)acetonitrile (11b). – Either hydrazine hydrate (0.15 g, 
0.003 mol) or phenyl hydrazine (0.324 g, 0.003 mol) was added to a solution of compound 1 
(0.423 g, 0.003 mol) in ethanol (50 mL). The reaction mixture was stirred at room tempera-
ture for 24 h and the formed solid product, in each case, was collected by filtration and 
recrystallized from 1,4-dioxane.
2-(5-(2-Oxo-2-phenylethylthio)-1,3,4-oxadiazol-2-yl)acetonitrile (12). – Phenacylbromide 
(0.6 g, 0.003 mol) was added to the dry solid of compound 1 (0.423 g, 0.003 mol) in ethanol 
(50 mL). The reaction mixture was heated under reflux for 3 h and then left to cool. The 
remaining product was triturated with diethyl ether and the formed solid product was 
collected by filtration. It was recrystallized from 1,4-dioxane.
Ethyl 2-(5-(cyanomethyl)-1,3,4-oxadiazol-2-ylthio)acetate (13). – A suspension of com-
pound 1 (0.423 g, 0.003 mol) in ethanol (50 mL) was added to ethyl chloroacetate (0.37 g, 
0.003 mol). The reaction mixture was heated under reflux for 5 h, then left to cool and the 
remaining product was triturated with diethyl ether. The solid product so formed was 
collected by filtration and recrystallized from ethanol.
2-((2-(5-Thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-5,6-dihydro-4H-cyclopenta[b]-thiophen-
3-yl-imino)methyl)malononitrile (14a) and 2-((2-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-4,5,6,7-
tetrahydrobenzo [b] thiophen-3-ylimino)methyl)malononitrile (14b). – To a mixture of either com-
pound 4a (0.478 g, 0.002 mol) or 4b (0.507 g, 0.002 mol) and triethyl orthoformate (0.296 g, 
0.002) and malononitrile (0.132 g, 0.002 mol), a catalytic amount of piperidine was added. The 
reaction mixture was heated in an oil bath at 120 °C for 3 h. The mixture was then boiled in 
ethanol for a few minutes, poured onto an acidified ice/water mixture and the formed solid 
product, in each case, was collected by filtration and recrystallized from 1,4-dioxane.
Synthetic pathways are presented in Schemes 1–3. Structures of all the synthesized 
compounds were confirmed based on analytical and spectral data; physicochemical and 
spectral data of the synthesized compounds are given in Tables I and II.
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Biological evaluations
Antiviral activity tests: material and methods. – Antiviral activities of the synthesized 
compounds were evaluated following the procedures described before (14). We conducted 
Table I. Physicochemical data for the synthesized compounds
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antiviral and cytotoxic investigations for all synthesized compounds against 8 viruses in 
3 different cell lines. They included Herpes simplex virus-1 (KOS), thymidine kinase-defi-
cient HSV-1 KOS strain resistant to acyclovir (ACVr) (TK-KOS-ACVr), Herpes simplex virus-2 
(G), Vaccinia virus in HEL cell cultures; Vesicular stomatitis virus and Coxsackie virus B4 in 
HeLa cell cultures, and Feline herpes virus (FHV) and Feline corona virus (FCoV) in CRFK cell 
cultures. The HEL, HeLa and CRFK cell lines (Novartis Institutes for Biomedical Research, 
Basel, Switzerland) were monitored for mycoplasma contamination and were found to be 
mycoplasma free.
Inhibition of virus-induced cytopathogenicity in vitro. – Confluent cell cultures in microti-
ter trays were inoculated with 100 CCID50 (1 CCID50 corresponding to the virus stock dilu-
tion proven for infection of 50 % of cell cultures). After 1 h of virus adsorption to the cells, 
the residual virus was removed and replaced by cell culture medium (Eagle’s Minimum 
Essential Medium) containing 3 % fetal calf serum and various concentrations of test com-
pounds. Viral cytopathogenicity was recorded as soon as it reached completion in the 
untreated virus-infected cell cultures, that is, in 1 to 2 days for Vesicular stomatitis virus, in 
2 days for Coxsackie virus, in 2 to 3 days for Vaccinia virus and Herpes simplex virus types 1 
and 2. Antiviral activity of the compounds is expressed as the concentration required to 
inhibit viral cytopathogenicity by 50 % (IC50).
Cytotoxicity. – Cytotoxic activity was measured as an alteration of normal cell mor-
phology. Evaluation of cell morphology concerning confluent cell cultures that were not 
infected but were treated with various concentrations of test compounds were incubated 
in parallel with the virus-infected cell cultures and examined microscopically at the same 
time as viral cytopathogenicity was recorded in the virus-infected cell cultures. Disrup-
tion of the cell monolayer, e.g., rounding up or detachment of cells, was considered as evi-
dence for cytotoxicity. Cytotoxicity of both synthesized compounds and reference stan-
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dard drugs was determined as the minimum concentration required to cause a 
microscopically detectable alteration of normal cell morphology.
Fifty percent of effective concentration or concentration producing 50 % inhibition of 
virus-induced cytopathic effect (CC50) was determined by measuring the cell viability with 
the colorimetric formazan-based MTS assay.
DMSO was used as solvent for reference drugs and tested compounds while phos-
phate buffer saline was used as diluent.
RESULTS AND DISCUSSION
Chemistry
In the framework of our research group (15, 16), we here introduce some novel hetero-
cyclic compounds based on the 1,3,4-oxadiazole ring with potential antiviral and cyto-
toxic activities. In this article, we report the synthesis of thiophene-, thiazole-, coumarin-, 
pyridine- and pyridazine-bearing 1,3,4-oxadiazoles.
Cyanoacetic acid hydrazide reacted with carbon disulphide in ethanolic KOH to pro-
duce 1,3,4-oxadiazole derivative 1. The structure of compound 1 was in agreement with 1H 
NMR, which showed a singlet at δ 3.23-3.37 ppm due to the presence of the methylene 
group and a singlet at δ 11.72 ppm due to the existence of NH. Mass spectral fragmentation 
was consistent with the structure of compound 1. Compound 1 underwent a series of 
chemical reactions, thus aryldiazonium chlorides reacted with 1,3,4-oxadiazole derivative 
1 to produce arylhydrazone derivatives 2a-c. Structures of the latter compounds were 
verified by elemental analysis and spectral data: in compound 2a, 1H NMR spectrum in-
dicated the presence of a multiplet at δ 6.85-7.22 ppm which could be assigned to the 5H of 
the benzene ring and two singlets at δ 8.76 and 10.82 ppm corresponding to two NH 
groups. In the reaction of compound 1 with arylaldehydes, compounds 3a,b were ob-
tained. Also, compound 1 reacted with either cyclopentanone or cyclohexanone in the 
presence of elemental sulfur and triethylamine to afford fused thiophene derivatives 4a,b, 
resp. 1H NMR spectrum of compound 4a indicated the presence of a multiplet at δ 1.87-2.05 
ppm, which could be assigned to three CH2 groups, a singlet at δ 4.42 ppm, which indi-
cated the presence of the NH2 group, a singlet at δ 10.65 ppm corresponding to the NH 
group. Furthermore, 13C NMR spectrum revealed three signals at δ 21.7, 26.2 and 28.9 ppm 
for the three CH2 groups in the cyclopentene ring, four signals at δ 130.7, 133.4, 138.7 and 
141.5 ppm for the thiophene ring, and two signals at δ 145.6 and 155.3 ppm for the 1,3,4-oxa-
diazole ring (Scheme 1).
Thiazole derivatives 5a,b were obtained through the reaction of 1,3,4-oxadiazole de-
rivative 1 with either ethylisothiocyanate or phenylisothiocyanate in the presence of ele-
mental sulfur and trimethylamine. Structures of compounds 5a,b were established: in 
compound 5a, 1H NMR spectrum showed the presence of a triplet at δ 1.45 ppm corre-
sponding to the CH3 group, a quartet at δ 4.12 ppm which was assigned to the presence of 
the CH2 group, a singlet at δ 4.88 ppm which indicated the presence of the NH2 group and 
a singlet at δ 10.28 ppm corresponding to the NH group. In addition, 13C NMR spectrum 
showed a signal at δ 16.5 ppm for the CH3 group, a signal at δ 37.8 ppm for the CH2 group, 
three signals at δ 135.2, 139.1 and 145.7 ppm were for the thiazole ring and two signals at δ 
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Scheme 1
158.4 and 167.5 ppm for the 1,3,4-oxadiazole ring. Furthermore, the reaction of 1,3,4-oxa-
diazole derivative 1 with salicylaldehyde afforded coumarin derivative 6. Also, compound 
1 reacted with either acetylacetone or acetoacetanilide to form compounds 7a,b. Their 
structures were confirmed: 1H NMR spectrum of compound 7a indicated the presence of 
two singlets at δ 2.23 and 2.38 ppm assignable to two CH3 groups, a singlet at δ 4.18 ppm 
which indicates the presence of the CH2 group and a singlet at δ 11.13 ppm corresponding 
to the NH group. Compound 7b underwent cyclization to afford pyridine derivative 8. The 
structure of compound 8 was established according to the IR spectra indicating the pres-
ence of two stretching vibration bands for the NH2 group at n 3388 and 3316 cm–1 in addi-
tion to the 1H NMR spectrum indicating the presence of a singlet at δ 1.95 ppm correspond-
ing to the CH3 group, a singlet at δ 5.23 ppm indicating the  NH2 group, a  multiplet at δ 
6.92-7.41 ppm which indicated the presence of five H atoms of the benzene ring, and one H 
of the pyridine ring singlet at δ 9.82 ppm corresponding to the NH group. Moreover, the 
mass spectrum revealed m/z at 301 [M+1]+, m/z at 300 [M]+ and m/z at 77 [C6H5]+ for the 
phenyl moiety (Scheme 2).
Reaction of compound 7a with aryldiazonium chlorides afforded compounds 9a,b; the 
latter products underwent cyclization to produce pyridazine derivatives 10a,b. 1H NMR 
spectrum of compound 10a indicated the presence of two singlets at δ 1.88 and 2.34 ppm 
corresponding to two CH3 groups, a multiplet at δ 7.17-7.35 ppm which indicated the pres-
272
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ence of five hydrogens of the benzene 
ring, two singlets at δ 9.23 and 9.86 ppm 
corresponding to two NH groups. When 
1,3,4-oxadiazole derivative 1 reacted 
with hydrazine derivatives, hydrazone 
derivatives 11a,b were obtained. 1H NMR 
spectrum of compound 11a indicated 
the presence of a singlet at δ 3.39-3.44 
ppm corresponding to the CH2 group, a 
singlet at δ 5.17 ppm which indicated the 
presence of NH2, a singlet at δ 9.55 ppm 
corresponding to the NH group.
Furthermore, compound 1 reacting 
with either bromoacetophenone or ethyl 
chloroacetate afforded compounds 12 
and 13, resp. Their structures were in 
agreement with analytical and spectral 
data (Scheme 2).
Finally, the reaction of fused thio-
phene derivatives 4a,b with a mixture 
of triethyl orthoformate and malononi-
trile afforded compounds 14a,b. IR 
spectra indicated the absence of stretch-
ing vibration bands of the NH2 group in 
compound 14a. 1H NMR spectrum indi-
cated the presence of a multiplet at δ 
1.98-2.17 ppm which could be assigned 
to three CH2 groups, two doublets at δ 
4.57 and 5.68 ppm which indicated the 
presence of two hydrogens (CH, CH=), a 
singlet at δ 10.86 ppm corresponding to 
the NH group (Scheme 3).
Antiviral activity and QSAR
Compounds 5a,b showed the high-
est antiviral activities against Feline her-
pes virus, Feline corona virus, Herpes sim-
plex virus-1 and Herpes simplex virus-2, 
which may be due to the presence of the 
amino thiazole moiety. Compounds 4a, 
10a,b and 14a,b exhibited moderate an-
tiviral activities, while the remaining 
compounds did not show any appre-
ciable activities comparable with the 
reference standards, ganciclovir, acy-
clovir and cidofovir (Table III).
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As far as Vaccinia virus and Herpes simplex virus (TK-KOS-ACVr ), Coxsackie virus B4 and 
Vesicular stomatitis viruses are concerned, compound 11b was considered the most active 
with respect to reference standards ganciclovir, acyclovir, cidofovir and ribavirin. This 
may be due to the presence of the phenyl hydrazonoyl group. Compounds 13 and 14a,b 
were considered to be more effective products among the compounds; this may be due to 
the existence of ethylthioacetate and iminomethyl malononitrile groups, resp. The other 
tested compounds exhibited very low activity. In regard to cytotoxic activity, compounds 
5a,b showed high cytotoxicity, which may due to the presence of the aminothiazole moiety. 
Further, compounds 4a,b were considered as more cytotoxic agents compared to the other 
compounds; this may be due to the presence of the amino group on the fused thiophene 
ring. The other compounds acted as weak or inactive cytotoxic agents (Table III).
CONCLUSIONS
In this article, the synthesized 1,3,4-oxadiazoles containing thiophene, thiazole, couma-
rin, pyridine and pyridazine moieties were evaluated as cytotoxic and antiviral agents. 
Among the newly synthesized compounds, thiazole derivatives 5a,b were proven to be the 
most active antiviral agents against Feline corona virus, Feline herpes virus, Herpes simplex vi-
rus-1 and Herpes simplex virus-2. Compound 11b was proven as the most effective compound 
against Vaccinia virus, Herpes simplex virus (TKKOSACVr), Vesicular stomatitis viruses and Cox-
sackie virus B4 versus reference standards (ganciclovir, acyclovir, cidofovir and ribavirin). 
Among the remaining compounds, compounds 13 and 14a,b were found most effective.
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